• Mashup Score: 1

    9 Octobe r 2023, Cairo, Egypt – The World Health Organization (WHO) congratulates Egypt for its unprecedented progress towards eliminating hepatitis C, becoming the first country to achieve “gold tier” status on the path to elimination of hepatitis C as per WHO criteria. Achieving the gold tier means that Egypt has fulfilled the programmatic requirements that facilitate the reduction of new hepatitis C infections and deaths to levels that position the country to end the hepatitis C epidemic. Globally, 58

    Tweet Tweets with this article
    • Egypt becomes the first country to achieve WHO validation on the path to elimination of hepatitis C https://t.co/vQE5qx0Mil #LiverTwitter #IDTwitter #NoHep @WHOEMRO

  • Mashup Score: 6

    In 2022, the Global Fund to Fight AIDS, Tuberculosis and Malaria made a welcome move to enable increased financial support for viral hepatitis. International organisations and patient groups have called on countries to include viral hepatitis prevention and treatment services in their national proposals to the Global Fund, and also called on funders such as the US President’s Emergency Plan for AIDS Relief (PEPFAR) to integrate viral hepatitis into their programmes.1

    Tweet Tweets with this article
    • New Correspondence - Khwairakpam et al - HIV pre-exposure prophylaxis as an entry point to the elimination of hepatitis B virus https://t.co/FQ0cQHskeF #TREATAsia @amfAR @Hep_Alliance @hepatitisfund #NoHep #HBV #HIV

  • Mashup Score: 0

    In The Lancet Gastroenterology & Hepatology, the Polaris Observatory Collaborators report their latest iteration of the modelling of HBV prevalence, cascade of care, and prophylaxis.1 Some refinements have been made to the modelling, with better quality data, which have led to an estimated global burden of HBV infection of 257·5 million (95% uncertainty interval 216·6–316·4) in 2022—a reduction of around 34·5 million cases compared with the 292·0 million estimated for 2016.2 By contrast, Cui and colleagues’ recent study,3 which used WHO-collected data, estimated that 295·9 million (95% CI 228·2–422·6) people were living with chronic HBV infection in 2019.

    Tweet Tweets with this article
    • Linked Comment by @SengGeeLim1 - WHO 2030 HBV elimination goals: a goal too far? https://t.co/3Cd9qbSBuU #NoHep #HBV #WorldHepatitisDay #LiverTwitter #IDTwitter https://t.co/0bjE173eFY

  • Mashup Score: 10

    In 2008, the World Hepatitis Alliance launched the World Hepatitis Day in honour of the birthday of Dr Baruch Blumberg (July 28, 1925), who discovered the hepatitis B virus (HBV) in 1967. The worldwide number of deaths per year attributable to HBV was estimated at 700 000 in 2013. This number is projected to increase to 1·3 million per year by 2040, which is more than the annual number of deaths related to HIV/AIDS (741 000), tuberculosis (875 000), or malaria (332 000).1

    Tweet Tweets with this article
    • New Correspondence - Vo-Quang et al - Poor disease knowledge among people living with hepatitis B in The Gambia and Tanzania https://t.co/cZuNZ9cIVw #LiverTwitter #IDTwitter #WorldHepatitisDay #NoHep #HepCantWait #NotWaiting #HBV @maud_lemoine @ErwanVoQuang @gndow https://t.co/ijK3JKArGY

  • Mashup Score: 1

    The 2021 WHO global progress report on HIV, viral hepatitis, and sexually transmitted infections estimated that globally, 354 million people were living with chronic HBV or HCV infection in 2019, causing 1·11 million deaths.1 In WHO’s Eastern Mediterranean Region (EMR), 18 million people were living with chronic HBV infection and 12 million with chronic HCV infection, causing 63 000 deaths.1 The Global Burden of Disease estimated that in 2019, in the EMR, hepatitis B and C were responsible for 3·4 million disability-adjusted life-years lost and caused chronic liver diseases, including cancers and cirrhosis, in 35 million people.

    Tweet Tweets with this article
    • New Comment - Sabry Alaama et al - Time to scale up testing and treatment for HBV and HCV in the WHO Eastern Mediterranean Region https://t.co/B4W0jKJMwz @WHOEMRO @hepatitisfund @CHAI_health #NoHep #LiverTwitter #IDTwitter #WorldHepatitisDay

  • Mashup Score: 1

    On March 9, 2023, US President Joseph Biden’s administration proposed an US$11 billion, 5-year national hepatitis C virus (HCV) elimination programme. If passed by Congress, the ambitious plan aims to speed US Food & Drug Administration (FDA) approval of rapid point-of-care RNA testing and to dramatically expand access to screening, direct-acting antiviral (DAA) treatment, and monitoring.

    Tweet Tweets with this article
    • RT @LancetGastroHep: News - $11 billion US hepatitis C elimination plan proposed https://t.co/TAhmml9AlA #nohep #livertwitter #idtwitter…

  • Mashup Score: 0

    On March 9, 2023, US President Joseph Biden’s administration proposed an US$11 billion, 5-year national hepatitis C virus (HCV) elimination programme. If passed by Congress, the ambitious plan aims to speed US Food & Drug Administration (FDA) approval of rapid point-of-care RNA testing and to dramatically expand access to screening, direct-acting antiviral (DAA) treatment, and monitoring.

    Tweet Tweets with this article
    • News - $11 billion US hepatitis C elimination plan proposed https://t.co/TAhmml9AlA #nohep #livertwitter #idtwitter @BryantFurlow